
Childhood Cancer Awareness Month
September is Childhood Cancer Awareness Month. Just us to raise awareness about childhood cancer, and help us to create brighter futures for children with cancer.
Who we are
Expertise.

Without CCLG, I don't think I could do my job as well as I do. Being a member enables us to give the best care we can for our patients and their familiesDr Nicky Thorp, Consultant Clinical Oncologist, The Christie

Expert clinical work
Together with our professional members, we shape better treatment and care—developing guidelines, sharing expertise, offering advice, leading groundbreaking research, and creating essential resources and education for professionals.

Advising government policy
We use our expertise and influence to make things better. By campaigning, advocating and working alongside governments, the NHS, and other organisations, we’re pushing for progress and shaping a brighter future for young lives.

Trusted patient information
We provide trusted information and guidance for children and young people with cancer, their families, and everyone supporting them. Our expertise helps them navigate the challenges of cancer and its impact, offering reassurance and clarity when it’s needed most.
Progress.
-
84 %
survival rate
in children compared to 20% in the 1960s, thanks to advances in research
-
125
research projects
funded in the last ten years with the support of research partners

Community.
Leading powerful collaborations

Child Cancer Smart
A collaborative project which will measure, understand and improve the time it takes to diagnose children and young people with all cancers across the UK.

Children’s Cancer Priority Setting Partnership
Bringing together patients, families, professionals and families to improve outcomes for every type of cancer and ensure every child and young person goes on to lead a long, healthy, and happy life.
Latest News & Updates

Why does neurodegeneration occur in Langerhans cell histiocytosis?
A small number of patients with Langerhans cell histiocytosis (LCH) may develop a difficult-to-treat condition called neurodegeneration, where their nerve cells slowly stop working and die. It typically affects the brain causing clumsy movements,…

60 seconds with Prof Bob Phillips
Professor Bob Phillips is the Candlelighters Chair of Supportive Care Research for Children and Young People with Cancer, University of York, Consultant Paediatric Oncologist at Leeds Children’s Hospital and CCLG member.

Ask the expert: Jennifer Laidler
Jennifer Laidler, from the University of Birmingham’s Cancer Research UK Clinical Trials Unit, talks about what clinical trials are and why they are important.